Acutus CEO Vince Burgess leaves

  • Push-out Score determined
  • After about five years in the position
  • Praise for Burgess
  • David Roman taking over temporarily
  • Search for a successor
  • Burgess made a lengthy statement and said 217 words

(exechange) — Carlsbad, California, May 12, 2022 — Vince Burgess, chief executive of Acutus, leaves — “under mutually agreeable terms.” As announced by Acutus Medical Inc. in a news release and in a regulatory filing published on Thursday, May 12, 2022, Vince Burgess leaves his post as chief executive officer at the arrhythmia management company, after about five years in the role, effective May 13, 2022.

Acutus will undertake a search for a successor.

Vince Burgess’s duties as CEO will be taken over temporarily by David Roman, most recently chief financial officer at Acutus Medical Inc., as Interim Chief Executive Officer.

“This is an appropriate time to step away”

Vince Burgess’s departure from the CEO post is explained as follows. Burgess said: “Reflecting on the evolution of the business and our journey, I believe this is an appropriate time to step away from my role as President and CEO.”

Precise information regarding Vince Burgess’s future plans was not immediately available.

“Stepping down/departing”

Acutus said: “Vince Burgess [is] stepping down as the Company’s President and Chief Executive Officer.”

Acutus further said: “On May 12, 2022, the Company also announced that Vince Burgess was departing from his position as President and CEO of the Company, as well as a member of the Company’s board of directors, under mutually agreeable terms, effective May 13, 2022.”

“Not related to a disagreement”

“Mr. Burgess’ resignation was not related to a disagreement with the Company on any matter relating to the Company’s operations, policies or practices,” Acutus said.

Share price decline since January 2021

The announcement follows a decline in Acutus Medical Inc.’s share price of 97% since January 2021.

In the position of CEO since 2017

Vince Burgess became CEO of the Company in 2017.

Burgess has served as the Company’s President and Chief Executive Officer since October 2017 and as a member of the Company’s Board of Directors since June 2013.

From September 2010 to June 2020, Burgess also served as a Venture Partner at OrbiMed Advisors, an investment company focused on the healthcare industry.

From 2002 to 2010, Burgess held various leadership positions at Volcano Corporation, where he was part of the founding team.

Since 2012, Burgess has served as a director of TELA Bio, Inc., a medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials. Burgess also serves on the boards of a number of private medical technology companies.

Burgess received a B.S. in Business Administration and Entrepreneurship from the University of Southern California and an M.B.A. from University of California, Los Angeles.

Push-out Score determined

The Push-out Score™ determined by exechange gauges the pressure surrounding Vince Burgess’s move on a scale of 0 to 10.

exechange reached out to Acutus and offered the company the opportunity to comment on the score.

Read the full story in the exechange report 20.2022 ($).